NCT04127422

Brief Summary

Benign diseases of the breast are common clinical conditions that affect young women. Complaints related to the breast often cause significant discomfort and mental stress. The following study will try to identify the risk factors that may be associated with symptomatic benign breast diseases. Identification of such factors may help preventing and / or treating these conditions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 10, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 15, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

November 28, 2019

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2021

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2021

Completed
Last Updated

November 19, 2020

Status Verified

November 1, 2020

Enrollment Period

1.2 years

First QC Date

October 10, 2019

Last Update Submit

November 18, 2020

Conditions

Keywords

Benign breast diseaseFibrocystic disease

Outcome Measures

Primary Outcomes (4)

  • Relative risk of benign breast disease associated with obesity.

    For the study and control groups, body mass index will be calculated as the weight (Kg) to square height (m) ratio.

    This outcome will be assessed at baseline (the first hospital visit).

  • Relative risk of benign breast disease associated with soda beverage consumption.

    for the study and control groups, the participant will be asked about soda beverage consumption in the last 30 days. never consumed is scored 0 (lowest score). Three or more times a day is scored 9 (highest score).

    This outcome will be assessed at baseline (the first hospital visit).

  • Relative risk of benign breast disease associated with caffeine beverages consumption.

    for the study and control groups, the participant will be asked about caffeine beverage consumption in the last 30 days. never consumed is scored 0 (lowest score). Three or more times a day is scored 9 (highest score).

    This outcome will be assessed at baseline (the first hospital visit).

  • Relative risk of benign breast disease associated with parity.

    for the study and control groups, the participant will be asked about her parity. response will be either nullipara, primipara, multipara or grand multipara ( 5 or more births).

    This outcome will be assessed at baseline (the first hospital visit).

Other Outcomes (1)

  • Relative risk of benign breast disease associated with hormonal contraception.

    This outcome will be assessed at baseline (the first hospital visit).

Study Arms (2)

Study group

Patients presenting with current symptoms related to the breast. Adult females aged 18-39 years presenting to the breast outpatient clinic with either mastalgia, nodularity and/or discharge. A questionnaire, physical examination and bilateral breast ultrasonography will be obtained for all patients. A- The questionnaire will contain the following items: 1. symptoms related to the breast. 2. other medical history. 3. menstrual history. 4. obstetric history. 5. rapid screener for beverages and fast food consumption. 6. rapid screener for vegetables and fruit consumption. B- Physical examination will specifically records the following: 1. breast tender point(s). 2. breast nodularity. 3. nipple discharge. 4. weight, height, body mass index (BMI). C- bilateral breast ultrasonography for all patients. D- breast biopsy when clinically indicated as per hospital policy.

Control group

Age-matched healthy volunteers with no current medical conditions. Adult females aged 18-39 years with no current breast problems. These healthy volunteers will be asked to complete the same questionnaire as per the Study group and have anthropometric measure. A- The questionnaire will contain the following items: 1. other medical history. 2. menstrual history. 3. obstetric history. 4. rapid screener for beverages and fast food consumption. 5. rapid screener for vegetables and fruit consumption. B- Physical examination will specifically records the following: 1- weight, height, body mass index (BMI).

Eligibility Criteria

Age18 Years - 39 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Adult females presenting to the breast outpatient clinic at Mansoura University Oncology Center.

You may qualify if:

  • adult females with current symptoms related to the breast.

You may not qualify if:

  • Current or past malignancy of the breast.
  • Discrete breast mass that necessitate work-up to exclude cancer.
  • Current psychiatric morbidity.
  • Persons unwilling to participate.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura University Cancer center

Al Mansurah, 35516, Egypt

RECRUITING

MeSH Terms

Conditions

Cystic Fibrosis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Surgery

Study Record Dates

First Submitted

October 10, 2019

First Posted

October 15, 2019

Study Start

November 28, 2019

Primary Completion

February 1, 2021

Study Completion

April 1, 2021

Last Updated

November 19, 2020

Record last verified: 2020-11

Locations